Nyxoah Investor Relations Material
Latest events
Q1 2025
Nyxoah
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Nyxoah S.A.
Access all reports
Nyxoah S.A. is a medical technology company that specializes in developing and commercializing innovative treatments for Obstructive Sleep Apnea (OSA). The company's flagship product, the Genio system, offers a patient-centric and CE-Marked hypoglossal neurostimulation therapy designed to treat moderate to severe cases of OSA. This therapy serves as an alternative for patients who are unable or unwilling to tolerate Continuous Positive Airway Pressure (CPAP) treatments. The company is headquartered in Mont-Saint-Guibert, Belgium, and its shares are listed on the NASDAQ.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
NYXH
Country
🇺🇸 United States